These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

363 related items for PubMed ID: 30151927

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Flotillin-2 promotes nasopharyngeal carcinoma metastasis and is necessary for the epithelial-mesenchymal transition induced by transforming growth factor-β.
    Zhao L, Lin L, Pan C, Shi M, Liao Y, Bin J, Liao W.
    Oncotarget; 2015; 6(12):9781-93. PubMed ID: 25909165
    [Abstract] [Full Text] [Related]

  • 4. YPEL3 suppresses epithelial-mesenchymal transition and metastasis of nasopharyngeal carcinoma cells through the Wnt/β-catenin signaling pathway.
    Zhang J, Wen X, Ren XY, Li YQ, Tang XR, Wang YQ, He QM, Yang XJ, Sun Y, Liu N, Ma J.
    J Exp Clin Cancer Res; 2016 Jul 11; 35(1):109. PubMed ID: 27400785
    [Abstract] [Full Text] [Related]

  • 5. MiRNA-34a reversed TGF-β-induced epithelial-mesenchymal transition via suppression of SMAD4 in NPC cells.
    Huang G, Du MY, Zhu H, Zhang N, Lu ZW, Qian LX, Zhang W, Tian X, He X, Yin L.
    Biomed Pharmacother; 2018 Oct 11; 106():217-224. PubMed ID: 29960168
    [Abstract] [Full Text] [Related]

  • 6. Study on the value of Inhibin B in the diagnosis of nasopharyngeal carcinoma and its correlation with traditional Chinese medicine syndromes: An observational study.
    Ma N, Deng X, Liu Q, Xu F, Guo Q, Yan K, Yang Y, Zou G.
    Medicine (Baltimore); 2024 Jun 07; 103(23):e38416. PubMed ID: 38847724
    [Abstract] [Full Text] [Related]

  • 7. Deficiency of pigment epithelium-derived factor in nasopharyngeal carcinoma cells triggers the epithelial-mesenchymal transition and metastasis.
    Zhang T, Yin P, Zhang Z, Xu B, Che D, Dai Z, Dong C, Jiang P, Hong H, Yang Z, Zhou T, Shao J, Xu Z, Yang X, Gao G.
    Cell Death Dis; 2017 Jun 01; 8(6):e2838. PubMed ID: 28569772
    [Abstract] [Full Text] [Related]

  • 8. FOXA1 reprograms the TGF-β-stimulated transcriptional program from a metastasis promoter to a tumor suppressor in nasopharyngeal carcinoma.
    Li J, Wang W, Chen S, Cai J, Ban Y, Peng Q, Zhou Y, Zeng Z, Li X, Xiong W, Li G, Yi M, Xiang B.
    Cancer Lett; 2019 Feb 01; 442():1-14. PubMed ID: 30392786
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Manganese superoxide dismutase mediates anoikis resistance and tumor metastasis in nasopharyngeal carcinoma.
    Li S, Mao Y, Zhou T, Luo C, Xie J, Qi W, Yang Z, Ma J, Gao G, Yang X.
    Oncotarget; 2016 May 31; 7(22):32408-20. PubMed ID: 27083052
    [Abstract] [Full Text] [Related]

  • 13. High FMNL3 expression promotes nasopharyngeal carcinoma cell metastasis: role in TGF-β1-induced epithelia-to-mesenchymal transition.
    Wu Y, Shen Z, Wang K, Ha Y, Lei H, Jia Y, Ding R, Wu D, Gan S, Li R, Luo B, Jiang H, Jie W.
    Sci Rep; 2017 Feb 15; 7():42507. PubMed ID: 28198387
    [Abstract] [Full Text] [Related]

  • 14. Inflammatory CXCL12-CXCR4/CXCR7 axis mediates G-protein signaling pathway to influence the invasion and migration of nasopharyngeal carcinoma cells.
    Qiao N, Wang L, Wang T, Li H.
    Tumour Biol; 2016 Jun 15; 37(6):8169-79. PubMed ID: 26715277
    [Abstract] [Full Text] [Related]

  • 15. High expression of Zinc-finger protein X-linked is associated with reduced E-cadherin expression and unfavorable prognosis in nasopharyngeal carcinoma.
    Li Y, Yan X, Yan L, Shan Z, Liu S, Chen X, Zou J, Zhang W, Jin Z.
    Int J Clin Exp Pathol; 2015 Jun 15; 8(4):3919-27. PubMed ID: 26097576
    [Abstract] [Full Text] [Related]

  • 16. UBE2T promotes nasopharyngeal carcinoma cell proliferation, invasion, and metastasis by activating the AKT/GSK3β/β-catenin pathway.
    Hu W, Xiao L, Cao C, Hua S, Wu D.
    Oncotarget; 2016 Mar 22; 7(12):15161-72. PubMed ID: 26943030
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.